TABLE 1: CHARACTERISTICS OF THE INCLUDED STUDIES
STUDY PATIENTS COUNTRY JOURNAL TYPE OF SURGERY TREATMENT ARMS TREATMENT START BEFORE SURGERY FOLLOW-UP
Allah et al. 25 (2019)
61
Egypt
Journal of Cardiothoracic and Vascular Anesthesia
Valve Surgery
Atorvastatin (80 mg) versus Placebo
12 hours
5 days
Baran et al. 26 (2011)
60
Turkey
Stem Cell Reviews and Reports
CABG
Atorvastatin (40 mg) versus Placebo
-
30 days
Billings et al. 27 (2016)
199
USA
JAMA
Multiple
Atorvastatin (variable) versus Placebo
variable
until hospital discharge
Dehghani et al. 28 (2015)
58
Iran
Journal of Cardiovascular Pharmacology and Therapeutics
Valve Surgery
Atorvastatin (40 mg) versus Placebo
3 days
5 days
JI et al. 29 (2009)
140
China
Circulation Journal
CABG
Atorvastatin (20 mg) versus Placebo
7 days
13 days
Mannacio et al. 30 (2008)
200
Italy
The Journal of Thoracic and Cardiovascular Surgery
CABG
Rosuvastatin (20 mg) versus Placebo
7 days
25 days
Osmanovic et al. 31 (2019)
160
Bosnia
Medical Archives
CABG
Rosouvastatin 20 mg versus Placebo
7-10 days
until hospital discharge
Park et al. 32 (2016)
200
Korea
Intensive Care Medicine
Multiple
Atorvastatin (variable) versus Placebo
12-24 h
until hospital discharge
Patti et al. 33 (2006)
200
Italy
Circulation
Multiple
Atorvastatin (40 mg) versus Placebo
7 days
30 days
Song et al. 34 (2008)
124
Korea
American Heart Journal
CABG
Atorvastatin (20 mg) versus Placebo
3 days
30 days
Spadaccio et al. 35 (2010)
50
Italy
Journal of Cardiovascular Pharmacology
CABG
Atorvastatin (20 mg) versus Placebo
21 days
7 days
Sun et al. 36 (2011)
100
China
International Heart Journal
CABG
Atorvastatin (20 mg) versus Placebo
7 days
14 days
Vukovic et al. 37 (2011)
52
Serbia
Perfusion
CABG
Atorvastatin (20 mg) versus Placebo
21 days
-
Zheng et al. 38 (2016)
1269
China
NEJM
CABG and Aortic Valve Replacement Rosuvastatin (20 mg) versus Placebo
8 days
5 days